The Central Drugs Standard Control Organisation (CDSCO) has directed all states and Union Territories to strengthen inspections and monitoring of Chloramphenicol and Nitrofurans, antibiotics banned in food-producing animals. This move comes after nearly 43% of Indian shrimp export rejections by the US, European Union, and Japan this year were linked to residues of these banned drugs.
Background of the Issue
The Marine Products Export Development Authority (MPEDA) flagged the continued detection of banned antibiotics in export shipments, prompting stronger oversight of veterinary medicine outlets. According to the regulator, violations were traced to more than 40 farms, with Andhra Pradesh accounting for 46% of the cases, followed by Odisha (24%), West Bengal (19%), and Gujarat (11%).
CDSCO's Directives
CDSCO has asked states to furnish details on how the ban is being implemented, including the number of inspections carried out at veterinary drug shops and related establishments, and actions taken against violators. The regulator has also directed states to ensure these drugs are sold only through licensed channels for permitted purposes, with violations attracting action under the Drugs and Cosmetics Act and Rules.
The issue underscores the challenges faced by India's shrimp export industry, which is a significant contributor to the country's seafood exports. The US, EU, and Japan are key markets, and non-compliance with international food safety standards can lead to trade disruptions and reputational damage.
Stricter enforcement of the ban on Chloramphenicol and Nitrofurans is critical to maintaining market access and ensuring the safety of Indian seafood products. The CDSCO's directive aims to address these concerns through enhanced monitoring and penal actions against violators.
